Back to Trades
Total Value
$866.6K
Filing Date
Jul 24, 2026
1 transactions
Trade Summary
On Jul 24, 2026, ROBIN HOWARD W, Insider, reported $866.6K of NEKTAR THERAPEUTICS (NKTR) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $15.15. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- NEKTAR THERAPEUTICS
- Ticker Symbol
- NKTR
- CIK
- 0000906709
Insider Information
- Name
- ROBIN HOWARD W
- Role
- Insider
- Location
- SAN FRANCISCO, CA
Filing Details
- Filing Date
- Jul 24, 2026
- Transaction Date
- Jul 24, 2026
- Accession Number
- 0001193125-26-316457
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 24, 2026 | NKTR derivative | 57,200 | $15.15 | Grant/Award | $866.6K |
Want live alerts when ROBIN HOWARD W trades again?
Download Insider Trades to track NKTR, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)These stock options were granted on December 13, 2024 under the 2017 Amended and Restated Performance Incentive Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of five years from the date of grant.
- (F2)The Organization and Compensation Committee of the Board of Directors of the Issuer determined on July 23, 2026 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on July 24, 2026 (subject to remaining time-based vesting requirements).